ECJ opinion may not resolve dual pricing issue
This article was originally published in Scrip
Executive Summary
Dual pricing schemes designed to restrict parallel trade are a restriction of competition in the opinion of Verica Trstenjak, advocate general at the European Court of Justice, but this may not resolve a long-running court case involving GlaxoSmithKline and the European Commission.